Any questions?

Experimental Therapeutics

Taught programmes

MSc in Experimental Therapeutics (part-time)

Course Code | 003801

The Department of Oncology's Clinical Pharmacology Division and the Department for Continuing Education’s CPD Centre offer a part-time taught MSc in Experimental Therapeutics.

Taught by leading clinicians and scientists, the programme aims to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.

The flexible, modular structure of the part-time programme has been devised to suit busy professionals in full-time employment.

The six compulsory modules comprise:

  • The Structure of Clinical trials and Experimental Therapeutics
  • Drug Development, Pharmokinetic and Imaging
  • Pharmacodynamics, Biomarkers and Personalised Therapy
  • Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
  • How to do Research on Therapeutic Interventions: Protocol Preparation
  • Biological Therapeutics

Each module includes access to online resources as well as one week of intensive face-to-face teaching in Oxford. In addition, students will produce a dissertation based on a research project.

  • Length of programme: Usually two to three years, up to a maximum of four years

How to Apply

For application deadlines for the MSc in Experimental Therapeutics, please see the Continuing Education website.

The standard set of materials you should send with any application to a taught course comprises:

Please follow the detailed instructions in the Application Guide, and consult the Continuing Education website for any additional guidance.

Academic resources

University libraries, including:

  • Rewley House Continuing Education Library
  • Radcliffe Science Library

Other resources, including:

  • A virtual learning environment 

Academic staff profiles

Professor Leonard Seymour

  • Professor of Gene Therapies
  • Director of Clinical Pharmacology Division, Department of Oncology, University of Oxford
  • General Secretary of the European Society of Gene and Cell Therapy

Dr Jeffrey K. Aronson

  • Reader in Clinical Pharmacology at the University of Oxford
  • Honorary Consultant Physician in the Oxford Radcliffe Hospitals Trust

Dr Elaine Johnstone

Senior Research Fellow, Translational Oncology Research Group, Clinical Pharmacology Division, Department of Oncology, University of Oxford

Dr Stefan Knapp

Principal Investigator, Phosphorylation Dependent Signalling Group, Structural Genomics Consortium, University of Oxford

Dr Rachel Midgley

Clinical Director, Oncology Clinical Trials Office, Department of Oncology, University of Oxford

Dr Grant D Vallance

Information Manager, Department of Clinical Haematology, Cancer and Haemotology Centre, Churchill Hospital

Graduate destinations

Most part-time students on these programmes are already in full-time employment in related fields on commencement of the programmes.

Spacer

+44 (0)1865 286955
expther@conted.ox.ac.uk

 

 

 

 

 

Selection criteria

Selection criteria on the Continuing Education website External link

 

English language requirements

Higher level


Funding/awards

Oxford Funding Search External link

 

Number of applicants
2012/13

12


Number of places available
2013/14

20


Statement of Provision

Experimental Therapeutics - Taught External link